Shuxiang Li

95 Yong An Road
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis.

Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis.

Journal: BMC gastroenterology

Published: September 02, 2025

Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.

Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.

Journal: Journal of gastroenterology

Published: August 11, 2025

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Journal: European journal of gastroenterology & hepatology

Published: May 09, 2025

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patients.

Journal: European journal of gastroenterology & hepatology

Published: May 09, 2025

Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia.

Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia.

Journal: The American journal of surgical pathology

Published: December 20, 2024

Patients with AMA/anti-sp100/anti-gp210 Positivity and Cholestasis Can Manifest Conditions Beyond Primary Biliary Cholangitis.

Patients with AMA/anti-sp100/anti-gp210 Positivity and Cholestasis Can Manifest Conditions Beyond Primary Biliary Cholangitis.

Journal: Journal of clinical and translational hepatology

Published: October 11, 2024

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomena.

Journal: Therapeutic advances in gastroenterology

Published: August 16, 2023

IL-33 promotes double negative T cell survival via the NF-κB pathway.

IL-33 promotes double negative T cell survival via the NF-κB pathway.

Journal: Cell death & disease

Published: August 31, 2022

Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).

Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021).

Journal: Journal of clinical and translational hepatology

Published: July 22, 2022

The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC.

The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC.

Journal: Hepatology communications

Published: May 23, 2022

A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine.

A New Nano Adjuvant of PF3 Used for an Enhanced Hepatitis B Vaccine.

Journal: Frontiers in bioengineering and biotechnology

Published: March 24, 2022

Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitis.

Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitis.

Journal: Hepatology international

Published: August 30, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026